Influence of severe sarcopenia on cardiovascular risk factors in nonobese men

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 6, 2012, Pages 407-412

  Abe, Takashi ^a   Thiebaud, Robert S ^b   Loenneke, Jeremy P ^b   Bemben, Michael G ^b   Loftin, Mark ^a   Fukunaga, Tetsuo ^c  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c NATIONAL INSTITUTE OF FITNESS AND SPORTS IN KANOYA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ECHOCARDIOGRAPHY; HEALTH STATUS; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE MASS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; HUMANS; IDEAL BODY WEIGHT; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SARCOPENIA; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84869784070     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0057     Document Type: Article

References (22)

1. Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol 2003;95:1717-1727. (Pubitemid 37169320)
2. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763. (Pubitemid 28183275)
3. Janssen I. 2006. Influence of sarcopenia on the development of physical disability: The Cardiovascular Health Study. J Am Geriatr Soc 2006;54:56-62.
4. Dufour AB, Hannan MT, Murabito JM, et al. Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: The Framingham study. J Gerontol A Biol Sci Med Sci 2012; doi: 10.1093/gerona/ gls109 (in press).
5. Aubertin-Leheudre M, Lord C, Goulet EDB, et al. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity 2006;14:2277-2283. (Pubitemid 46121985)
6. Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 2009;13: 460-466.
7. Messier V, Karelis AD, Lavoie M-E, et al. Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: A MONET study. Appl Physiol Nutr Metab 2009;34:18-24.
8. Lim KI, Yang SJ, Kim TN, et al. The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: The Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol 2010;73:588-594.
9. Kohara K, Ochi M, Tabara Y, et al. Leptin in sarcopenic visceral obesity: Possible link between adipocytes and myocytes. PLos One 2012;6:e24633.
10. Abe T, Bemben MG, Kondo M, et al. Comparison of skeletal muscle mass to fat-free mass ratios among different ethnic groups. J Nutr Health Aging 2012;16:534-538.
11. Sanada K, Kearns CF, Midorikawa T, et al. Prediction and validation of total and regional skeletal muscle mass by ultrasound in Japanese adults. Eur J Appl Physiol 2006;96:24-31. (Pubitemid 43013287)
12. Abe T, Kondo M, Kawakami Y, et al. Prediction equations for body composition of Japanese adults by B-mode ultrasound. Am J Hum Biol 1994;6:161-170.
13. Brozek J, Grande F, Anderson JT, et al. Densitometric analysis of body composition: Revision of some quantitative assumptions. Ann NY Acad Sci 1963;110:113-140.
14. Abe T, Fukunaga T. Relationships between subcutaneous fat and muscle distributions and serum HDL-cholesterol. J Atheroscler Thromb 1994;1:15-22.
15. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978;19:65-72.
16. Van Gaal LF, Vansant GA, De Leeuw IH. Upper body adiposity and the risk for atherosclerosis. J Am Coll Nutr 1989;8:504-514.
17. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Matab Care 2012;15:12-22.
18. Barter PJ, Rye K-A. The rationale for using apo A-I as a clinical marker of cardiovascular risk. J Intern Med 2006;259: 447-454.
19. Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr 2012;32: Apr 23. [Epub ahead of print] (in press).
20. Koba S, Tanaka H, Maruyama C, et al. Physical activity in the Japan population: Association with blood lipid levels and effects in reducing cardiovascular and all-cause mortality. J Atheroscler Thromb 2011;18:833-845
21. Abe T, Kawakami Y, Bemben MG, et al. Comparison of agerelated, site-specific muscle loss between young and old active and inactive Japanese women. J Geriatr Phys Ther 2012;34:168-173.
22. Frontera WR, Meredith CN, O'Reilly KP, et al. Strength conditioning in older men: Skeletal muscle hypertrophy and improved function. J Appl Physiol 1988;64:1038-1044. (Pubitemid 18088522)